BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2554576)

  • 1. Synthesis of functional bovine leukemia virus (BLV) p34tax protein by recombinant baculoviruses.
    Chen G; Willems L; Portetelle D; Willard-Gallo KE; Burny A; Gheysen D; Kettmann R
    Virology; 1989 Nov; 173(1):343-7. PubMed ID: 2554576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abundant synthesis of functional human T-cell leukemia virus type I p40x protein in eucaryotic cells by using a baculovirus expression vector.
    Jeang KT; Giam CZ; Nerenberg M; Khoury G
    J Virol; 1987 Mar; 61(3):708-13. PubMed ID: 3027397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the bovine leukemia virus transactivator protein p34 by a recombinant vaccinia virus.
    Willems L; Letellier C; Gonze M; Martin R; Kettmann R; Burny A; Meulemans G
    Vet Immunol Immunopathol; 1989 Oct; 22(3):201-11. PubMed ID: 2560852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of bovine leukemia virus transactivator Tax with bZip proteins.
    Boros IM; Tie F; Giam CZ
    Virology; 1995 Dec; 214(1):207-14. PubMed ID: 8525616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat.
    Willems L; Kettmann R; Chen G; Portetelle D; Burny A; Derse D
    J Virol; 1992 Feb; 66(2):766-72. PubMed ID: 1309910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation.
    Willems L; Heremans H; Chen G; Portetelle D; Billiau A; Burny A; Kettmann R
    EMBO J; 1990 May; 9(5):1577-81. PubMed ID: 2158445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay.
    Jeang KT; Shank PR; Rabson AB; Kumar A
    J Virol; 1988 Oct; 62(10):3874-8. PubMed ID: 2843682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and functional characterization of mutants of the bovine leukaemia virus trans-activator protein p34tax.
    Sakurai M; Taneda A; Nagoya H; Sekikawa K
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2527-31. PubMed ID: 1655959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
    Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
    Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
    Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
    Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
    Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.
    Tajima S; Aida Y
    J Virol; 2000 Dec; 74(23):10939-49. PubMed ID: 11069988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency.
    Calomme C; Dekoninck A; Nizet S; Adam E; Nguyên TL; Van Den Broeke A; Willems L; Kettmann R; Burny A; Van Lint C
    J Virol; 2004 Dec; 78(24):13848-64. PubMed ID: 15564493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression.
    Kiermer V; Van Lint C; Briclet D; Vanhulle C; Kettmann R; Verdin E; Burny A; Droogmans L
    J Virol; 1998 Jul; 72(7):5526-34. PubMed ID: 9621009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino acid (157-197) peptide segment of bovine leukemia virus p34tax encompass a leucine-rich globally neutral activation domain.
    Willems L; Kettmann R; Burny A
    Oncogene; 1991 Jan; 6(1):159-63. PubMed ID: 1846955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
    Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
    Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
    Derse D
    J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression.
    Calomme C; Nguyen TL; de Launoit Y; Kiermer V; Droogmans L; Burny A; Van Lint C
    J Biol Chem; 2002 Mar; 277(11):8775-89. PubMed ID: 11741930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A downstream regulatory element activates the bovine leukemia virus promoter.
    Kiss-Tóth E; Unk I
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1553-61. PubMed ID: 8060339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.